BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 20430441)

  • 21. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
    Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular surface epithelial cells up-regulate HLA-G when expanded in vitro on amniotic membrane substrates.
    Higa K; Shimmura S; Shimazaki J; Tsubota K
    Cornea; 2006 Jul; 25(6):715-21. PubMed ID: 17077667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How Does the maternal immune system contribute to the development of pre-eclampsia?
    Moffett A; Hiby SE
    Placenta; 2007 Apr; 28 Suppl A():S51-6. PubMed ID: 17292469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-G inhibits the transendothelial migration of human NK cells.
    Dorling A; Monk NJ; Lechler RI
    Eur J Immunol; 2000 Feb; 30(2):586-93. PubMed ID: 10671215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
    Lilienfeld BG; Crew MD; Forte P; Baumann BC; Seebach JD
    Xenotransplantation; 2007 Mar; 14(2):126-34. PubMed ID: 17381687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The soluble pool of HLA-G produced by human trophoblasts does not include detectable levels of the intron 4-containing HLA-G5 and HLA-G6 isoforms.
    Blaschitz A; Juch H; Volz A; Hutter H; Daxboeck C; Desoye G; Dohr G
    Mol Hum Reprod; 2005 Oct; 11(10):699-710. PubMed ID: 16330474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of soluble HLA-G1 protecting porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
    Zeng MH; Fang CY; Wang SS; Zhu M; Xie L; Li R; Wang L; Wu XW; Chen S
    Transplant Proc; 2006 Dec; 38(10):3312-4. PubMed ID: 17175258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylation status and transcriptional expression of the MHC class I loci in human trophoblast cells from term placenta.
    Guillaudeux T; Rodriguez AM; Girr M; Mallet V; Ellis SA; Sargent IL; Fauchet R; Alsat E; Le Bouteiller P
    J Immunol; 1995 Apr; 154(7):3283-99. PubMed ID: 7897212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [HLA-G1 molecule expressed by ECV304 cells inhibit cytotoxic activity of allogeneic NK cells].
    Zhang CE; Han JY; Yang HJ; Wu XW; Huang YF; Liang ZH; Gong FL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Nov; 21(6):676-8. PubMed ID: 16256023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Truncated HLA-G isoforms are retained in the endoplasmic reticulum and insufficiently provide HLA-E ligands.
    Ulbrecht M; Maier S; Hofmeister V; Falk CS; Brooks AG; McMaster MT; Weiss EH
    Hum Immunol; 2004 Mar; 65(3):200-8. PubMed ID: 15041158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-effect of HLA-G1 and glycosyltransferases in reducing NK cell-mediated pig endothelial cell lysis.
    Miyagawa S; Nakai R; Matsunami K; Kusama T; Shirakura R
    Transpl Immunol; 2003; 11(2):147-53. PubMed ID: 12799197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse.
    Favier B; Lemaoult J; Lesport E; Carosella ED
    FASEB J; 2010 Mar; 24(3):689-99. PubMed ID: 19841038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uveal melanoma: no expression of HLA-G.
    Hurks HM; Valter MM; Wilson L; Hilgert I; van den Elsen PJ; Jager MJ
    Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3081-4. PubMed ID: 11726606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of NKG2D ligands in multidrug-resistant nasopharyngeal carcinoma cell line CNE2/DDP and their effects on cytotoxicity of natural killer cells].
    Mei JZ; Guo KY; Wei HM; Song CY
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):887-9. PubMed ID: 17584663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study on human leukocyte antigen G1 reducing xeno-cell-rejection by transfecting porcine endothelial cells].
    Xia Z; Han J; Wang S; Zeng R; Zhu M; Qi H; Chen D; Wu X; Gong F; Chen S
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Jun; 19(6):486-9. PubMed ID: 16038470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression of HLA-G protein in trophoblast cells].
    Wang YQ; Chen SL; Xing FQ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1488-90. PubMed ID: 16354612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Membrane-bound HLA-G activates proliferation and interferon-gamma production by uterine natural killer cells.
    van der Meer A; Lukassen HG; van Lierop MJ; Wijnands F; Mosselman S; Braat DD; Joosten I
    Mol Hum Reprod; 2004 Mar; 10(3):189-95. PubMed ID: 14981146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility to natural killer cell-mediated cytolysis is independent of the level of target cell class I HLA expression.
    Leiden JM; Karpinski BA; Gottschalk L; Kornbluth J
    J Immunol; 1989 Mar; 142(6):2140-7. PubMed ID: 2493507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells.
    LeMaoult J; Zafaranloo K; Le Danff C; Carosella ED
    FASEB J; 2005 Apr; 19(6):662-4. PubMed ID: 15670976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.